Nancy E. Dempze’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$898K Sell
16,500
-2,000
-11% -$97.4K 0.43% 46
2026
Q1
$793K Sell
18,500
-1,000
-5% -$43K 0.44% 47
2025
Q4
$855K Buy
19,500
+5,000
+34% +$207K 0.45% 46
2025
Q3
$599K Hold
14,500
0.33% 55
2025
Q2
$639K Sell
14,500
-1,500
-9% -$60K 0.37% 55
2025
Q1
$591K Hold
16,000
0.35% 56
2024
Q4
$533K Hold
16,000
0.31% 61
2024
Q3
$415K Buy
+16,000
New +$398K 0.23% 74

Other funds holding EXEL

Nancy E. Dempze's EXEL Position: Q2 2026 in Review

Nancy E. Dempze reduced its Exelixis (EXEL) stake by 11% in Q2 2026, selling an estimated $97.4K and leaving 16,500 shares worth $898K. The position accounts for 0.43% of the portfolio, ranked #46.

Nancy E. Dempze first reported a position in EXEL in Q3 2024 and has held it in 8 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Nancy E. Dempze held 16,500 shares of Exelixis worth $898K as of Q2 2026.
  • Nancy E. Dempze sold 2,000 Exelixis shares in Q2 2026, an estimated $97.4K.
  • Exelixis made up 0.43% of Nancy E. Dempze's portfolio in Q2 2026, its #46 holding.
  • Nancy E. Dempze first reported a position in Exelixis in Q3 2024 and has held it in 8 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Nancy E. Dempze's 13F filing for Q2 2026, filed 13 Aug 2026.